{"refrec":{"BRefID":263532,"RR":"Anti-Cancer Drugs. Lippincott Williams & Wilkins: Philadelphia.  ISSN 0959-4973; e-ISSN 1473-5741","BEntID":255551,"PublicFlag":1,"CheckedFlag":0,"wosflag":1,"vabbflag":null,"RefStringPartII":". Lippincott Williams & Wilkins: Philadelphia.  ISSN 0959-4973; e-ISSN 1473-5741","DocTypID":16,"DocType":"Journal","MarineFlag":0,"FreshFlag":0,"BrackishFlag":0,"TerrestrialFlag":0,"Authorstring":null,"OrigTitleTranslFlag":0,"Authorstringtrunc":null,"Englishabstract":null,"AbstractOtherLang":null,"BibLvlCode":"S","StandardTitle":"Anti-Cancer Drugs","OrigTitleLangCode":"en","OrigTitleLangCodeExtended":"eng","OrigTitleLangID":15,"DateLastModified":{"date":"2024-12-10 01:33:01.897972","timezone_type":1,"timezone":"+01:00"},"UserAccessRight":null,"UserAccID":null,"AuthorKeywords":null,"OtherDescriptors":null,"Notes":null,"AnaPub":null,"MonPub":null,"DateUpdate":"2016-10-07","DateCreate":"2016-10-07","SecASFANote":null,"ConfID":null,"PeerRev":1,"VlizCoreFlag":1,"WoScode":null,"VABBcode":null,"OpenAcc":0},"refs":null,"anarec":null,"monrec":null,"serrec":{"SerID":263532,"ISSN":"0959-4973","Abbreviation":null,"PublID":21970,"City":"Philadelphia","InpCentreCode":null,"ASFACode":null,"AntilopeFlag":0,"PerioID":null,"CurrentFlag":1,"PeerRevFlag":1,"DigISSN":"1473-5741","InputCentre":null,"Periodicity":null,"FromYear":null,"ToYear":null,"WoSFlag":1,"ISSNL":null,"EmbargoYears":null,"VABBFlag":0},"relations":null,"relationsRev":null,"addrec":null,"othpubs":null,"ownerships":null,"authors":null,"mapdetails":null,"datasets":null,"monographs":null,"monparts":null,"serparts":[{"BRefID":281071,"RR":"<b>van Kesteren, C.; Twelves, C.; Bowman, A.; Hoekman, K.; López-Lázaro, L.; Jimeno, J.; Guzman, C.; Mathôt, R.A.A.; Simpson, A.; Vermorken, J.B.; Smyth, J.; Schellens, J.H.; Hillebrand, M.J.X.; Rosing, H.; Beijnen, J.H.</b> (2002). Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I study. <i>Anti-Cancer Drugs 13(4)</i>: 381-393. <a href=\"http://dx.doi.org/10.1097/00001813-200204000-00007\" target=\"_blank\">dx.doi.org/10.1097/00001813-200204000-00007</a>","StandardTitle":"Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I study","AuthorsString":"van Kesteren, C. <i>et al.</i>","BibLvlCode":"AS"},{"BRefID":338237,"RR":"<b>Sparidans, R.W.; Rosing, H.; Hillebrand, M.J.X.; López-Lázaro, L.; Jimeno, J.M.; Manzanares, I.; van Kesteren, C.; Cvitkovic, E.; van Oosterom, A.T.; Schellens, J.H.M.; Beijnen, J.H.</b> (2001). Search for metabolites of ecteinascidin 743, a novel, marine-derived, anti-cancer agent, in man. <i>Anti-Cancer Drugs 12(8)</i>: 653-666. <a href=\"https://hdl.handle.net/10.1097/00001813-200109000-00003\" target=\"_blank\">https://hdl.handle.net/10.1097/00001813-200109000-00003</a>","StandardTitle":"Search for metabolites of ecteinascidin 743, a novel, marine-derived, anti-cancer agent, in man","AuthorsString":"Sparidans, R.W. <i>et al.</i>","BibLvlCode":"AS"}],"BEntOpen":null,"BEntPrivate":null,"availability":null,"litstyles":null,"thespers":null,"arch2discl":null,"SERpubls":null,"MONpubls":null,"pictures":[],"thestermsPath":null,"thestermsASFA":null,"taxtermsASFA":null,"geotermsASFA":null,"collections":null,"conf":null,"proj":null,"Physdatasets":null,"spcols":null,"doi":null,"publs":[{"PublID":21970,"PublName":"Lippincott Williams & Wilkins","InsID":null,"PersID":null,"INBOID":null,"OrderNr":null}],"serparttypes":["A"],"monauthors":null,"MParts":null,"SParts":null,"hLibs":null,"langs":null,"urls":null,"thesterms":null,"taxterms":null,"geoterms":null,"othterms":null,"asfacodes":null,"asfa2codes":null,"thestermsFRIS":null,"taxtermsFRIS":null,"geotermsFRIS":null,"othtermsFRIS":null,"resmessage":"","complete":1,"sessions":{"newSesName":"T'Jampens, Roeland, R.","newSesDate":{"date":"2016-10-07 15:17:03.940000","timezone_type":3,"timezone":"Europe/Brussels"},"updSesName":"T'Jampens, Roeland, R.","updSesDate":{"date":"2016-10-07 15:17:03.940000","timezone_type":3,"timezone":"Europe/Brussels"}}}